🇺🇸 FDA
Patent

US 9061055

Oncolytic adenovirus armed with therapeutic genes

granted A61KA61K31/513A61K35/761

Quick answer

US patent 9061055 (Oncolytic adenovirus armed with therapeutic genes) held by The Board of Regents of the University of Texas System expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/513, A61K35/761, A61K38/00, A61K38/177